SMMT
Summit Therapeutics Plc
Halal Rating :
Last Price
$19.13
Last updated:
Market Cap
-
7D Change
5.25%
1 Year Change
407.43%
Company Overview
Industries
Exchange
Next Earnings Date
Summit Therapeutics is a biopharmaceutical company focused on discovering, developing, and commercializing innovative medicines to treat serious unmet medical needs. The company is primarily focused on developing novel therapeutics for oncology and infectious diseases. Their lead product candidate, ivonescimab, is being developed in collaboration with Akeso Inc. for the treatment of various types of cancers.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Summit Therapeutics Plc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.